At the end of 2021, the global Peptide Antibiotics Market was estimated to be worth approximately US$ 4.4 billion. The market is expected to grow at a 6.6% CAGR and reach a value of US$ 8.3 billion by 2032.Given the increased prevalence of illnesses such as bloodstream infections, hospital-acquired infections, and b.
The Biosimilars and Biologics Market is expected to grow at a CAGR of 15.5% during the period 2022-2032. The market is valued at US$ 22,490.62 Mn in 2022 and is expected to reach a valuation of US$ 95,021.37 Mn by 2032.FMI, in its business report, elaborates the historical and current scenario of the global Biosimil.
/PRNewswire/ The "Muscle Relaxant Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com s offering. The global muscle relaxant.